DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Concord Biotech Limited — Board Meeting Intimation

NSE 1 hr ago·28 Jul 2026, 2:08 pm

Concord Biotech

Concord Biotech has announced a board meeting scheduled for July 31, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the quarter ending June 2026.

This announcement is a routine corporate disclosure that signals the upcoming release of key performance data. For investors, the quarterly results provide a critical snapshot of the company's operational health, profitability, and cash flow generation during the interim period.

Investors should monitor the release of these results for updates on revenue growth and margins. The market will likely react to the guidance provided by the management regarding future business prospects.